Atzpodien W, Kremer G J, Schnellbacher E, Denk R, Haferkamp G, Bierbach H
Dtsch Med Wochenschr. 1975 Feb 28;100(9):423-6. doi: 10.1055/s-0028-1106231.
In a 35-year-old man with the full picture of Fabry's disease there was an almost fourfold increase of trihexosylceramide concentration in plasma and a decrease in the alpha-galactosidase activity to 13 percent as compared with the values from a control group. Using the same biochemical methods it could be shown that two nephews of the patient are hemizygote carriers and that two sisters and the mother of the patient are heterozygote carriers. Causative treatment of the disease is unknown. In this patient the attacks of pain could be permanently improved with phenytoin and carbamazepin.
